Epidemiology of giant retinal tears in the United Kingdom: The British giant retinal tear epidemiology eye study (BGEES)

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4781-4787

  Ang, Ghee Soon ^a   Townend, John ^b   Lois, Noemi ^a  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CILIARY DISK; CRYOTHERAPY; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENDOTAMPONADE; FEMALE; GIANT RETINAL TEAR; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA FOVEA; RETINA TEAR; RETINOPEXY; UNITED KINGDOM; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY DETACHMENT; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; QUESTIONNAIRE; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETINAL PERFORATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS DETACHMENT; YOUNG ADULT;

EID: 77957360847     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5036     Document Type: Article

References (66)

1. Schepens CL, Dobble JG, Mc MJ. Retinal detachments with giant breaks: preliminary report. Trans Am Acad Ophthalmol Otolaryngol. 1962;66:471-479.
2. Scott JD. Giant tear of the retina. Trans Ophthalmol Soc U K. 1975;95:142-144.
3. Kanski JJ. Giant retinal tears. Am J Ophthalmol. 1975;79:846-852.
4. Freeman HM. Fellow eyes of giant retinal breaks. Trans Am Ophthalmol Soc. 1978;76:343-382.
5. Glasspool MG, Kanski JJ. Prophylaxis in giant tears. Trans Ophthalmol Soc U K. 1973;93:363-371.
6. Yorston DB, Wood ML, Gilbert C. Retinal detachment in East Africa. Ophthalmology. 2002;109:2279-2283.
7. Chou SC, Yang CH, Lee CH, et al. Characteristics of primary rhegmatogenous retinal detachment in Taiwan. Eye. 2007;21:1056-1061.
8. Malbran E, Dodds RA, Hulsbus R, Charles DE, Buonsanti JL, Adrogue E. Retinal break type and proliferative vitreoretinopathy in nontraumatic retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1990;228:423-425.
9. Thompson JA, Snead MP, Billington BM, Barrie T, Thompson JR, Sparrow JM. National audit of the outcome of primary surgery for rhegmatogenous retinal detachment. II. Clinical outcomes. Eye. 2002;16:771-777.
10. Thompson JA, Snead MP, Billington BM, Barrie T, Thompson JR, Sparrow JM. National audit of the outcome of primary surgery for rhegmatogenous retinal detachment. I. Sample and methods. Eye. 2002;16:766-770.
11. Foot B, Stanford M, Rahi J, Thompson J. The British Ophthalmological Surveillance Unit: an evaluation of the first 3 years. Eye. 2003;17:9-15.
12. Lean JS, Stern WH, Irvine AR, Azen SP. Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group. Ophthalmology. 1989;96:765-771.
13. Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 1998;43:3-18.
14. UK Office for National Statistics. http://www.statistics.gov.uk/cci/nugget.asp?id=6. Accessed December 03, 2009.
15. Drivers Medical Group, DVLA, Swansea. At a glance Guide to the current Medical Standards of Fitness to Drive. Available at: http://www.dvla.gov.uk/media/pdf/medical/aagv1.pdf. Accessed August 13, 2009.
16. Al-Khairi AM, Al-Kahtani E, Kangave D, Abu El-Asrar AM. Prognostic factors associated with outcomes after giant retinal tear management using perfluorocarbon liquids. Eur J Ophthalmol. 2008; 18:270-277.
17. Karel I, Michalickova M, Soucek P. Long-term results of pars plana vitrectomy and silicone oil for giant tears. Eur J Ophthalmol. 1996;6:315-321.
18. Ghosh YK, Banerjee S, Savant V, et al. Surgical treatment and outcome of patients with giant retinal tears. Eye. 2004;18:996-1000.
19. Unlu N, Kocaoglan H, Acar MA, Sargin M, Aslan BS, Duman S. The management of giant retinal tears with silicone oil. Eur J Ophthalmol. 2003;13:192-195.
20. Verstraeten T, Williams GA, Chang S, et al. Lens-sparing vitrectomy with perfluorocarbon liquid for the primary treatment of giant retinal tears. Ophthalmology. 1995;102:17-20.
21. Rofail M, Lee LR. Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina. 2005;25:897-901.
22. Aylward GW, Cooling RJ, Leaver PK. Trauma-induced retinal detachment associated with giant retinal tears. Retina. 1993;13:136-141.
23. Vidaurri-Leal J, de Bustros S, Michels RG. Surgical treatment of giant retinal tears with inverted posterior retinal flaps. Am J Ophthalmol. 1984;98:463-466.
24. Chang S, Lincoff H, Zimmerman NJ, Fuchs W. Giant retinal tears: surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol. 1989;107:761-766.
25. Leaver PK, Billington BM. Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: 5 years follow-up. Graefes Arch Clin Exp Ophthalmol. 1989;227:323-327.
26. Mathis A, Pagot V, Gazagne C, Malecaze F. Giant retinal tears. Surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina. 1992;12:S7-10.
27. Camacho H, Bajaire B, Mejia LF. Silicone oil in the management of giant retinal tears. Ann Ophthalmol. 1992;24:45-49.
28. Kertes PJ, Wafapoor H, Peyman GA, Calixto N, Jr, Thompson H. The management of giant retinal tears using perfluoroperhydrophenanthrene: a multicenter case series. Vitreon Collaborative Study Group. Ophthalmology. 1997;104:1159-1165.
29. Scott IU, Murray TG, Flynn HW Jr, Feuer WJ, Schiffman JC. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology. 2002; 109:1828-1833.
30. Sirimaharaj M, Balachandran C, Chan WC, et al. Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. Br J Ophthalmol. 2005;89:1176-1179.
31. Lee SY, Ong SG, Wong DW, Ang CL. Giant retinal tear management: an Asian experience. Eye. 2009;23(3):601-605.
32. Machemer R, Allen AW. Retinal tears 180 degrees and greater: management with vitrectomy and intravitreal gas. Arch Ophthalmol. 1976;94:1340-1346.
33. Goezinne F, EC LAH, Berendschot TT, et al. Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil. Retina. 2008;28:485-492.
34. Ambresin A, Wolfensberger TJ, Bovey EH. Management of giant retinal tears with vitrectomy, internal tamponade, and peripheral 360 degrees retinal photocoagulation. Retina. 2003;23:622-628.
35. Batman C, Cekic O. Giant retinal tears after pars plana vitrectomy. Eye. 1998;12:163-164.
36. Moore JK, Scott IU, Flynn HW Jr, et al. Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments. Ophthalmology. 2003;110:709-713, discussion 713-704.
37. Aaberg TM Jr, Rubsamen PE, Flynn HW Jr, Chang S, Mieler WF, Smiddy WE. Giant retinal tear as a complication of attempted removal of intravitreal lens fragments during cataract surgery. Am J Ophthalmol. 1997;124:222-226.
38. Ozdamar A, Aras C, Sener B, Oncel M, Karacorlu M. Bilateral retinal detachment associated with giant retinal tear after laser-assisted in situ keratomileusis. Retina. 1998;18:176-177.
39. Vilaplana D, Guinot A, Escoto R. Giant retinal tears after photorefractive keratectomy. Retina. 1999;19:342-343.
40. Rizzo S, Belting C, Genovesi-Ebert F. Two cases of giant retinal tear after implantation of a phakic intraocular lens. Retina. 2003;23: 411-413.
41. Cahill MT, Barry PJ, Kenna PF. Giant retinal tear in Usher syndrome type II: coincidence or association? Retina. 1998;18:177-178.
42. Clarkson JG, Blumenkranz MS, Culbertson WW, Flynn HW Jr, Lewis ML. Retinal detachment following the acute retinal necrosis syndrome. Ophthalmology. 1984;91:1665-1668.
43. Dowler JG, Lyons CJ, Cooling RJ. Retinal detachment and giant retinal tears in aniridia. Eye. 1995;9:268-270.
44. Johnston ME, Gonder JR. Giant retinal tears, retinal detachment and retinitis pigmentosa. Can J Ophthalmol. 1985;20:16-18.
45. Kim RY, Schwartz SD, Heckenlively JR, Gregor ZJ, Cooling RJ. Giant retinal tear and retinal detachment with underlying retinitis pigmentosa and hearing loss. Eye. 1996;10:697-700.
46. Topilow HW, Nussbaum JJ, Freeman HM, Dickersin GR, Szyfelbein W. Bilateral acute retinal necrosis: clinical and ultrastructural study. Arch Ophthalmol. 1982;100:1901-1908.
47. Hovland KR, Schepens CL, Freeman HM. Developmental giant retinal tears associated with lens coloboma. Arch Ophthalmol. 1968;80:325-331.
48. Kreiger AE, Lewis H. Management of giant retinal tears without scleral buckling: use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade. Ophthalmology. 1992;99:491-497.
49. Ie D, Glaser BM, Sjaarda RN, Thompson JT, Steinberg LE, Gordon LW. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy. Retina. 1994;14:323-328.
50. Hoffman ME, Sorr EM. Management of giant retinal tears without scleral buckling. Retina. 1986;6:197-204.
51. Chen CH, Tsai MH, Su CC, et al. Results of 12-year clinical study of giant retinal tear. Chang Gung Med J. 2001;24:633-639.
52. Batman C, Cekic O. Vitrectomy with silicone oil or long-acting gas in eyes with giant retinal tears: long-term follow-up of a randomized clinical trial. Retina. 1999;19:188-192.
53. Glaser BM. Treatment of giant retinal tears combined with proliferative vitreoretinopathy. Ophthalmology. 1986;93:1193-1197.
54. Kapetanios AD, Donati G, Pournaras CJ. Idiopathic giant retinal tears: treatment with vitrectomy and temporary silicone oil tamponade (in French). J Fr Ophtalmol. 2000;23:1001-1005.
55. Bottoni F, Bailo G, Arpa P, Prussiani A, Monticelli M, de Molfetta V. Management of giant retinal tears using perfluorodecalin as a postoperative short-term vitreoretinal tamponade: a long-term follow- up study. Ophthalmic Surg. 1994;25:365-373.
56. Glaser BM, Carter JB, Kuppermann BD, Michels RG. Perfluorooctane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology. 1991;98:1613-1621.
57. Freeman HM. Fellow eyes of giant retinal breaks. Mod Probl Ophthalmol. 1979;20:267-274.
58. Govan JA. Prophylactic circumferential cryopexy: a retrospective study of 106 eyes. Br J Ophthalmol. 1981;65:364-370.
59. Brasseur G, Charlin JF, Langlois J. The fellow eye in cases of giant tears of the retina: preventive attitude (in French). Bull Soc Ophtalmol Fr. 1985;85:215-218.
60. Meyer-Schwickerath G. Prevention and giant tears (in German). Bibl Ophthalmol. 1967;72:345-346.
61. Kreissig I, Robert Y. Prevention, in the contralateral eye, of a giant tear ablation (in German). Klin Monatsbl Augenheilkd. 1983;182:121-124.
62. Mastropasqua L, Carpineto P, Ciancaglini M, Falconio G, Gallenga PE. Treatment of retinal tears and lattice degenerations in fellow eyes in high risk patients suffering retinal detachment: a prospective study. Br J Ophthalmol. 1999;83:1046-1049.
63. Ang GS, Townend J, Lois N. Interventions for prevention of giant retinal tear in the fellow eye. Cochrane Database Syst Rev. 2009:CD006909.
64. Chauhan DS, Downie JA, Eckstein M, Aylward GW. Failure of prophylactic retinopexy in fellow eyes without a posterior vitreous detachment. Arch Ophthalmol. 2006;124:968-971.
65. Hovland KR. Vitreous findings in fellow eyes of aphakic retinal detachment. Am J Ophthalmol. 1978;86:350-353.
66. Avitabile T, Bonfiglio V, Reibaldi M, Torrisi B, Reibaldi A. Prophylactic treatment of the fellow eye of patients with retinal detachment: a retrospective study. Graefes Arch Clin Exp Ophthalmol. 2004;242:191-196.